Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "68822dd35b399ba6097ed11b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "SEIZMET G 0.5 FORTE",
"description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.",
"price": 125.0,
"discountamount": 38.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2151,
"imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-24T12:57:55.385Z",
"updatedon": "2025-07-24T12:57:55.385Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/seizmet-g-0-5-forte/2151",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "glimepiride and metformin hydrochloride tablets",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6797579a56219bc105ead8ff",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Bisoprolol (5mg)",
"description": "Bisoprolol 5mg\nBISOPROLIN 5 is a highly effective medication containing Bisoprolol 5mg, a beta-blocker that is widely used to manage various cardiovascular conditions. Bisoprolol is a selective beta-1 adrenergic receptor blocker, which helps in reducing heart rate, blood pressure, and the overall workload on the heart. It is commonly prescribed to treat conditions like hypertension (high blood pressure), chronic heart failure, and angina (chest pain). BISOPROLIN 5 is an essential component of heart disease management, designed to improve heart function, reduce symptoms, and prevent further complications.\n\nKey Uses of BISOPROLIN 5\n1. Management of Hypertension (High Blood Pressure)\nBISOPROLIN 5 is frequently prescribed for hypertension, as it effectively lowers high blood pressure, helping to reduce the risk of life-threatening complications such as heart attacks, strokes, and kidney damage. By blocking beta-1 receptors in the heart, it helps in lowering heart rate and blood pressure.\n\n2. Treatment of Chronic Heart Failure (CHF)\nChronic heart failure is a condition where the heart's ability to pump blood is impaired. BISOPROLIN 5 is commonly used to improve heart function and reduce symptoms of heart failure such as shortness of breath, swelling in the legs, and fatigue. By lowering the workload on the heart, it helps manage heart failure symptoms and prevent hospitalizations.\n\n3. Prevention of Angina (Chest Pain)\nBISOPROLIN 5 helps in managing angina by reducing the heart's oxygen demand, thus preventing episodes of chest pain caused by insufficient blood flow to the heart. It is especially beneficial in patients with stable angina or other ischemic heart conditions.\n\n4. Management of Cardiac Arrhythmias\nBISOPROLIN 5 is effective in managing cardiac arrhythmias (irregular heartbeats), particularly atrial fibrillation. It works by stabilizing the electrical activity in the heart and preventing abnormal rhythms, ensuring proper heart function.\n\nBenefits of BISOPROLIN 5\n1. Effective Blood Pressure Control\nBISOPROLIN 5 significantly helps in maintaining normal blood pressure levels. By reducing blood pressure, it helps prevent the complications associated with hypertension, such as heart attack, stroke, and kidney disease.\n\n2. Improvement in Heart Function\nFor patients suffering from heart failure, BISOPROLIN 5 helps to improve heart function by reducing the heart’s workload and optimizing its ability to pump blood. This results in a reduction of heart failure symptoms such as fatigue and fluid retention.\n\n3. Prevention of Angina Attacks\nFor those with angina, BISOPROLIN 5 helps prevent chest pain episodes and improves exercise tolerance by reducing the heart's oxygen demand.\n\n4. Reduced Risk of Cardiovascular Events\nBy lowering both blood pressure and heart rate, BISOPROLIN 5 helps reduce the risk of severe cardiovascular events like heart attacks and strokes.\n\nHow BISOPROLIN 5 Works\nBISOPROLIN 5 contains Bisoprolol, a beta-blocker that primarily affects the heart's beta-1 receptors. By binding to these receptors, Bisoprolol reduces the heart rate and the force of heart contractions. This helps the heart beat more efficiently and requires less oxygen, especially during periods of stress or activity. Additionally, Bisoprolol dilates blood vessels, leading to lower blood pressure.\n\nBy reducing the heart's workload, BISOPROLIN 5 not only manages hypertension and heart failure symptoms but also decreases the risk of arrhythmias and angina.\n\nDosage and Administration\nRecommended Dosage\nThe usual dose of BISOPROLIN 5 is 5mg once daily. The dose may vary depending on the condition being treated, the severity of the condition, and individual patient response. The medication is typically taken once a day, and it is important to follow the doctor's instructions for optimal results.\n\nHow to Take BISOPROLIN 5\nTake the tablet at the same time every day to ensure consistency.\nSwallow the tablet whole with water.\nBISOPROLIN 5 can be taken with or without food.\nDo not crush or chew the tablet.\nDo not stop taking the medication abruptly without consulting your healthcare provider, as this can worsen the condition.\nPossible Side Effects\nLike any medication, BISOPROLIN 5 may cause side effects. However, not everyone will experience them. Common side effects include:\n\nCommon Side Effects\nFatigue or Tiredness: Feeling excessively tired is a common side effect, especially in the initial stages of treatment.\nDizziness or Lightheadedness: This can occur, particularly when standing up quickly.\nSlow Heart Rate (Bradycardia): A reduced heart rate is a common effect of Bisoprolol.\nCold Extremities: Hands and feet may feel cold due to reduced blood flow.\nNausea or Upset Stomach: Mild stomach discomfort may be experienced.\nRare but Serious Side Effects\nSevere Bradycardia (Extremely Slow Heart Rate): If the heart rate drops too much, it may lead to fainting or severe dizziness.\nBreathing Problems: Difficulty breathing or wheezing, especially in individuals with asthma.\nSevere Allergic Reactions: Such as swelling of the face, lips, or throat.\nLiver Dysfunction: Signs of liver problems include jaundice, dark urine, or persistent nausea.\nIf any severe or persistent side effects occur, contact your healthcare provider immediately.\n\nDrug Interactions\nBISOPROLIN 5 may interact with certain medications, affecting its effectiveness or increasing the risk of side effects. Some common drug interactions include:\n\nOther Blood Pressure-Lowering Drugs: Combining BISOPROLIN 5 with other antihypertensive medications (e.g., calcium channel blockers or ACE inhibitors) may lead to excessively low blood pressure.\nAnti-arrhythmic Drugs: Medications for heart rhythm disorders, such as amiodarone or sotalol, may interact with Bisoprolol.\nInsulin or Oral Diabetes Medications: Bisoprolol can mask the symptoms of low blood sugar (hypoglycemia), so extra monitoring is needed in diabetic patients.\nNSAIDs (Non-Steroidal Anti-Inflammatory Drugs): These may reduce the blood pressure-lowering effect of BISOPROLIN 5.\nAntidepressants or Antipsychotics: Certain psychiatric medications may enhance Bisoprolol’s side effects, such as dizziness and fatigue.\nAlways inform your healthcare provider about all medications, supplements, and over-the-counter drugs you are currently taking.\n\nPrecautions and Warnings\n1. Who Should Avoid BISOPROLIN 5?\nPeople with severe asthma, COPD (Chronic Obstructive Pulmonary Disease), or other respiratory disorders.\nIndividuals with a history of heart block or very low heart rate (bradycardia).\nThose with uncontrolled heart failure or shock.\n2. Pregnancy and Breastfeeding\nBISOPROLIN 5 should only be used during pregnancy if absolutely necessary. It is not recommended for breastfeeding mothers, as it may pass into breast milk.\n\n3. Regular Monitoring\nIt is important to regularly monitor blood pressure and heart rate while taking BISOPROLIN 5. Liver and kidney function may also need to be checked periodically.\n\nLifestyle and Dietary Tips\nFollow a healthy, balanced diet with limited salt intake to support heart health.\nExercise regularly as recommended by your doctor, but avoid strenuous activity without proper consultation.\nLimit alcohol consumption to reduce potential interactions and side effects.\nQuit smoking to improve heart function and overall cardiovascular health.\nStorage Instructions\nStore BISOPROLIN 5 in a cool, dry place away from direct sunlight.\nKeep it out of reach of children to avoid accidental ingestion.\nDo not use the medication after the expiration date printed on the package.\nConclusion\nBISOPROLIN 5 is an effective treatment option for managing hypertension, chronic heart failure, angina, and arrhythmias. By improving heart function, lowering blood pressure, and reducing symptoms, it helps enhance the quality of life for patients with cardiovascular conditions. Always follow your doctor’s instructions regarding dosage, administration, and monitoring for the best outcomes.\n\n\n\n\n\n\n\n\n",
"price": 65.0,
"discountamount": 20.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"warnings 1",
"bisoprolin 5",
"helps prevent",
"manages hypertension",
"patients suffering",
"helps enhance",
"shock 2 pregnancy",
"extra monitoring",
"optimal results",
"usual dose",
"breath swelling",
"commonly prescribed",
"medication bisoprolin 5",
"lifethreatening complications",
"complications key",
"reducing symptoms",
"bisoprolol 5mg",
"breastfeeding bisoprolin 5",
"bisoprolin 5 antidepressants",
"water bisoprolin 5",
"impaired bisoprolin 5",
"medication abruptly",
"hearts workload",
"reduce symptoms",
"direct sunlight",
"breastfeeding mothers",
"taking precautions",
"overthecounter drugs",
"medications supplements",
"psychiatric medications",
"ace inhibitors",
"antihypertensive medications",
"medications affecting",
"persistent nausea",
"liver problems",
"face lips",
"experienced rare",
"treatment dizziness",
"initial stages",
"healthcare provider",
"stop taking",
"doctors instructions",
"vary depending",
"primarily affects",
"atrial fibrillation",
"stable angina",
"preventing episodes",
"managing angina",
"hearts ability",
"kidney damage",
"frequently prescribed",
"essential component",
"bisoprolol insulin",
"heart block",
"heart beat",
"heart contractions",
"angina dosage",
"angina attacks",
"treat conditions",
"electrical activity",
"pump blood",
"kidney function",
"heart attacks",
"side effects",
"dosage administration",
"cardiovascular conditions",
"heart rate",
"heart function",
"cardiovascular events",
"heart failure",
"blood pressure",
"common effect",
"administration recommended dosage",
"lowering heart rate",
"heart attacks strokes",
"reducing blood pressure",
"severe cardiovascular events",
"cardiovascular conditions bisoprolol",
"highly effective medication",
"heart failure symptoms",
"common side effects",
"hearts oxygen demand",
"dietary tips follow",
"reduce potential interactions",
"common side effect",
"effective treatment option",
"reduced heart rate",
"improve heart function",
"heart rate drops",
"respiratory disorders individuals",
"uncontrolled heart failure",
"receptors bisoprolol reduces",
"blood pressurelowering effect",
"lower blood pressure",
"heart rhythm disorders",
"heart attack stroke",
"avoid strenuous activity",
"hearts beta1 receptors",
"insufficient blood flow",
"common drug interactions",
"expiration date printed",
"avoid accidental ingestion",
"cool dry place",
"limited salt intake",
"healthy balanced diet",
"checked periodically lifestyle",
"calcium channel blockers",
"jaundice dark urine",
"feel cold due",
"ensure consistency swallow",
"individual patient response",
"improves exercise tolerance",
"chest pain caused",
"blocking beta1 receptors"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2039,
"imageuri": "https://productimages.withfloats.com/actual/679757d6b85fd002599105ef.png",
"tileimageuri": "https://productimages.withfloats.com/tile/679757d6b85fd002599105ef.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-01-27T09:53:30.652Z",
"updatedon": "2025-01-29T12:01:30.749Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/bisoprolol-5mg-/2039",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BISOPROLIN 5 ",
"category": "cardiology ",
"tags": [
"Bisoprolol 5 mg uses",
"Bisoprolol 5 mg price in India",
"Is 5 mg of bisoprolol a low dose",
"Bisoprolol fumarate 5 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "668e8611b9f7300708fe1240",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRIOGLIMITERIS 1/0.2 ",
"description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n",
"price": 195.0,
"discountamount": 58.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"500 mg",
"0.2 mg",
"one tablet",
"Weight gain",
"Glimepiride 1",
"metformin use",
"Proper dosage",
"Glimepiride (1",
"dosage regimen",
"typical dosage",
"renal function",
"insulin release",
"drug metabolism",
"Lactic acidosis",
"Close monitoring",
"dose adjustments",
"renal impairment",
"diabetic patients",
"insulin secretion",
"different aspects",
"Drug Interactions",
"other medications",
"Regular monitoring",
"Dosage adjustments",
"Allergic reactions",
"peripheral tissues",
"hepatic metabolism",
"glucose metabolism",
"insulin sensitivity",
"healthcare provider",
"Hepatic dysfunction",
"Common side effects",
"abdominal discomfort",
"different mechanisms",
"liver function tests",
"diabetic ketoacidosis",
"pancreatic beta cells",
"combination medication",
"carbohydrate digestion",
"comprehensive approach",
"serious adverse effect",
"Metformin Hydrochloride",
"carbohydrate absorption",
"sulfonylurea derivative",
"glucose-dependent manner",
"optimal glycemic control",
"type 1 diabetes mellitus",
"type 2 diabetes mellitus",
"More severe side effects",
"alpha-glucosidase enzymes",
"peripheral glucose uptake",
"hepatic glucose production",
"alpha-glucosidase inhibitor",
"individual patient response",
"personalized treatment plans",
"optimal therapeutic outcomes",
"Gastrointestinal disturbances",
"intestinal glucose absorption",
"other antidiabetic medications",
"other oral antidiabetic agents",
"postprandial blood glucose levels",
"other significant medical conditions"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1939,
"imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-07-10T13:01:05.875Z",
"updatedon": "2024-07-10T13:01:05.875Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TRIOGLIMITERIS 1/0.2 ",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride 1mg+metformin 500mg+voglibose 0.2 mg",
"Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b",
"glimepiride 2mg+metformin 500mg+voglibose 0.2 mg",
"voglibose glimepiride & metformin hydrochloride (s",
"voglibose glimepiride + metformin hydrochloride us",
"glimepiride 1mg+metformin 500mg+voglibose 0.3 mg",
"glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g",
""
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "668e7ff07e47881008f6860e",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRIMETAZ CR 80 ",
"description": "TRIMETAZ CR 80 \nTrimetazidine (80mg)\nIntroduction\nTRIMETAZ CR 80 is a medication containing Trimetazidine hydrochloride, formulated to treat angina pectoris and certain other cardiovascular conditions. It is known for its metabolic effects on the heart muscle, improving myocardial efficiency and reducing symptoms associated with ischemic heart disease.\n\nComposition\n\nTrimetazidine (80mg): The active ingredient, Trimetazidine, acts as a cellular metabolic agent that enhances myocardial glucose utilization and improves energy production in the heart muscle.\nMechanism of Action\nTrimetazidine exerts its therapeutic effects through several mechanisms:\n\nMetabolic Regulation: Shifts myocardial energy substrate utilization from fatty acids toward glucose oxidation, which is more efficient and requires less oxygen.\nAnti-ischemic Effect: Protects the heart against ischemic damage by preserving cellular energy metabolism and reducing oxidative stress.\nImprovement in Symptomatology: Reduces angina symptoms such as chest pain, shortness of breath, and exercise intolerance by enhancing myocardial function.\nIndications\nTRIMETAZ CR 80 is indicated for:\n\nChronic Stable Angina Pectoris: Used as adjunctive therapy in patients who are inadequately controlled with other anti-anginal medications.\nIschemic Heart Disease: Helps improve myocardial function and reduce symptoms associated with coronary artery disease.\nDosage and Administration\n\nThe usual dosage of TRIMETAZ CR 80 is one tablet (80mg) taken orally twice daily, preferably with meals.\nThe extended-release formulation ensures sustained therapeutic levels of Trimetazidine throughout the day.\nDosage adjustments may be necessary based on individual patient response and tolerance.\nSide Effects\nCommon side effects may include:\n\nHeadache\nDizziness\nNausea\nGastrointestinal disturbances (such as abdominal pain or diarrhea)\nSevere side effects are rare but may include:\n\nAllergic reactions (rash, itching, swelling)\nExtrapyramidal symptoms (involuntary movements)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with severe renal impairment or hepatic dysfunction, as Trimetazidine metabolism may be altered.\nMonitor patients for signs of extrapyramidal symptoms, especially in patients with Parkinson's disease or other movement disorders.\nAvoid abrupt discontinuation of Trimetazidine, as it may worsen angina symptoms.\nDrug Interactions\n\nTrimetazidine may interact with other medications that affect myocardial metabolism or cardiac function, including beta-blockers and calcium channel blockers. Close monitoring is recommended when used concomitantly.\nConclusion\nTRIMETAZ CR 80 is a valuable therapeutic option for managing chronic stable angina pectoris and ischemic heart disease by improving myocardial efficiency and reducing symptoms associated with cardiac ischemia. Its mechanism of action, focusing on metabolic modulation and anti-ischemic effects, makes it an effective adjunctive therapy in patients with inadequate symptom control on standard anti-anginal medications. Proper dosage, administration, and monitoring for side effects are essential to ensure safe and effective use of TRIMETAZ CR 80 in cardiovascular patients. Consultation with a healthcare provider is recommended for personalized treatment plans and management of cardiac conditions with TRIMETAZ CR 80.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n",
"price": 435.0,
"discountamount": 130.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"one tablet",
"chest pain",
"less oxygen",
"fatty acids",
"TRIMETAZ CR",
"usual dosage",
"heart muscle",
"Proper dosage",
"effective use",
"abdominal pain",
"angina symptoms",
"ischemic damage",
"Close monitoring",
"cardiac ischemia",
"oxidative stress",
"cardiac function",
"Drug Interactions",
"active ingredient",
"glucose oxidation",
"metabolic effects",
"energy production",
"other medications",
"Dosage adjustments",
"Allergic reactions",
"adjunctive therapy",
"several mechanisms",
"cardiac conditions",
"healthcare provider",
"Hepatic dysfunction",
"myocardial function",
"therapeutic effects",
"Severe side effects",
"Common side effects",
"metabolic modulation",
"Metabolic Regulation",
"liver function tests",
"involuntary movements",
"anti-ischemic effects",
"myocardial efficiency",
"myocardial metabolism",
"abrupt discontinuation",
"ischemic heart disease",
"Extrapyramidal symptoms",
"cardiovascular patients",
"coronary artery disease",
"severe renal impairment",
"Trimetazidine metabolism",
"cellular metabolic agent",
"other movement disorders",
"calcium channel blockers",
"cellular energy metabolism",
"inadequate symptom control",
"Trimetazidine hydrochloride",
"valuable therapeutic option",
"individual patient response",
"extended-release formulation",
"sustained therapeutic levels",
"personalized treatment plans",
"Gastrointestinal disturbances",
"other anti-anginal medications",
"myocardial glucose utilization",
"Chronic Stable Angina Pectoris",
"other cardiovascular conditions",
"standard anti-anginal medications",
"myocardial energy substrate utilization"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1938,
"imageuri": "https://productimages.withfloats.com/actual/668e7ff3f07c99c3af8e8504.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/668e7ff3f07c99c3af8e8504.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-07-10T12:34:56.538Z",
"updatedon": "2024-07-10T12:34:56.538Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trimetaz-cr-80-/1938",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TRIMETAZ CR 80 ",
"category": "CARDIOLOGYRANGE",
"tags": [
"Trimetazidine 80mg price",
"Trimetazidine 35 mg uses",
"Trimetazidine 80 mg brand name",
"When to stop taking trimetazidine",
"Trimetazidine hydrochloride extended release CAPSU",
"Trimetazidine mechanism of action",
"Trimetazidine 35 mg brand name",
""
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "668e77e853fc1c2298508399",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TENELIGOLD PIO 20/15 ",
"description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n",
"price": 149.0,
"discountamount": 44.7,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"key role",
"one tablet",
"Weight gain",
"common cold",
"risk factors",
"dual therapy",
"Heart failure",
"increased risk",
"dosage regimen",
"typical dosage",
"Bladder Cancer",
"Bone fractures",
"adipose tissue",
"TENELIGOLD PIO",
"glucose uptake",
"dose adjustment",
"fluid retention",
"glucagon release",
"DPP-4) inhibitor",
"safety parameters",
"CYP2C8 Inhibitors",
"Drug Interactions",
"incretin hormones",
"different aspects",
"Regular monitoring",
"treatment outcomes",
"Dosage adjustments",
"peripheral tissues",
"single formulation",
"glucagon secretion",
"potential benefits",
"glucose metabolism",
"insulin sensitivity",
"Pioglitazone levels",
"Hepatic dysfunction",
"Common side effects",
"different mechanisms",
"dual-action approach",
"liver function tests",
"blood glucose levels",
"dipeptidyl peptidase-4",
"healthcare professional",
"optimal glycemic control",
"type 2 diabetes mellitus",
"More severe side effects",
"potential adverse effects",
"hepatic glucose production",
"Pioglitazone concentrations",
"individual patient response",
"two antidiabetic medications",
"other cardiovascular diseases",
"other antidiabetic medications",
"existing cardiovascular disease",
"glucose-dependent insulin secretion",
"peroxisome proliferator-activated receptor gamma"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1935,
"imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-07-10T12:00:40.528Z",
"updatedon": "2024-07-10T12:00:40.528Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//teneligold-pio-20-15-/1935",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TENELIGOLD PIO 20/15 ",
"category": "DIABETIC RANGE",
"tags": [
"teneligliptin + pioglitazone brand name",
"Zita Plus Pio",
"Teneligliptin + Pioglitazone Metformin",
"Zita Piomet 1000",
"Teneligliptin 20 MG and Pioglitazone 15 MG tablets",
"Dapagliflozin",
"Zita Piomet 500"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66602642dce9381dfcc57613",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "PRAZOPRIME XL 5",
"description": "PRAZOPRIME XL 5\nPrazosin SR 5.0\nPRAZOPRIME XL 5 is a potent medication formulated with Prazosin SR 5.0, designed to manage hypertension effectively. Prazosin SR 5.0, a sustained-release formulation, ensures consistent blood pressure control throughout the day.\n\nThis medication works by relaxing blood vessels, allowing blood to flow more smoothly, thus reducing the workload on the heart and lowering blood pressure. It is commonly prescribed for patients with hypertension, a condition that can lead to serious health complications if left unmanaged.\n\nThe extended-release nature of Prazosin SR 5.0 in PRAZOPRIME XL 5 provides convenience by requiring fewer daily doses compared to immediate-release formulations. This helps improve medication adherence and enhances treatment outcomes.\n\nPatients using PRAZOPRIME XL 5 should follow their healthcare provider's instructions regarding dosage and administration. Regular monitoring of blood pressure and periodic check-ups are essential for optimal management of hypertension.\n\nLike all medications, PRAZOPRIME XL 5 may have potential side effects such as dizziness, fatigue, and low blood pressure. It is crucial to report any unusual symptoms to your doctor promptly.\n\nConsult your healthcare provider to determine if PRAZOPRIME XL 5 is suitable for your hypertension management needs.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/prazoprime-xl-5-134147\n\n\n\n\n\n\n",
"price": 275.0,
"discountamount": 83.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"Call",
"heart",
"Email",
"dosage",
"doctor",
"product",
"fatigue",
"WhatsApp",
"patients",
"workload",
"condition",
"dizziness",
"Prazosin SR",
"medications",
"information",
"convenience",
"instructions",
"sterisonline",
"sterispharma",
"blood vessels",
"PRAZOPRIME XL",
"administration",
"unusual symptoms",
"fewer daily doses",
"potent medication",
"low blood pressure",
"Regular monitoring",
"treatment outcomes",
"optimal management",
"periodic check-ups",
"healthcare provider",
"medication adherence",
"potential side effects",
"extended-release nature",
"serious health complications",
"sustained-release formulation",
"hypertension management needs",
"immediate-release formulations",
"consistent blood pressure control"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1351,
"imageuri": "https://productimages.withfloats.com/actual/666026464b2b24fcd89ab870.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666026464b2b24fcd89ab870.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T08:48:02.694Z",
"updatedon": "2024-06-29T12:47:41.555Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/prazoprime-xl-5/1351",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PRAZOPRIME XL 5",
"category": "CARDIOLOGYRANGE",
"tags": [
"PRAZOPRIME XL 5",
"Prazosin SR 5.0",
"Prazopress XL 5 uses",
"Prazopress XL 5 side effects",
"Prazopress XL 5 Uses in Hindi",
"Prazopress XL 5 generic Name"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6634c4a9ae1cfd0bbc282281",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "BOSENTIME 125",
"description": "BOSENTIME 125\nBosentan (125mg)\n\"Bosentime 125\" is a medication containing Bosentan in a strength of 125mg. Bosentan is a type of medication known as an endothelin receptor antagonist. It works by blocking the action of endothelin, a substance in the body that narrows blood vessels and increases blood pressure. Here are key points about Bosentime 125:\n\nPurpose: Bosentime 125 is primarily used to treat pulmonary arterial hypertension (PAH). PAH is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart.\nDosage: The usual recommended dose of Bosentime 125 for adults with PAH is 125mg twice daily, taken orally. It is important to follow your doctor's instructions regarding dosage and frequency.\nAdministration: Bosentime 125 tablets should be taken with food to improve absorption. Swallow the tablets whole with water and do not crush or chew them.\nEffectiveness: Bosentan helps to relax and widen the blood vessels in the lungs, which reduces the workload on the heart and improves exercise capacity in individuals with PAH.\nMonitoring: Regular monitoring of liver function is necessary while taking Bosentime 125, as it can affect liver enzymes. Your doctor may perform blood tests to check liver function periodically.\nSide Effects: Common side effects of Bosentime 125 may include headache, flushing, nasal congestion, and liver function abnormalities. It is essential to report any unusual symptoms to your healthcare provider.\nPrecautions: Bosentan can cause birth defects if taken during pregnancy. It is important to use effective contraception while taking this medication and to avoid pregnancy. Inform your doctor if you are pregnant or planning a pregnancy.\nInteractions: Bosentan may interact with certain medications, including hormonal contraceptives, cyclosporine, and certain HIV medications. Inform your doctor about all medications you are taking before starting Bosentime 125.\nStorage: Store Bosentime 125 tablets at room temperature away from moisture and heat. Keep them out of reach of children and pets.\nConsultation: Always consult your doctor or healthcare provider for personalized advice and guidance regarding the use of Bosentime 125, including dosage adjustments and potential drug interactions.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n",
"price": 1351.0,
"discountamount": 405.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"use",
"pets",
"heat",
"food",
"dose",
"type",
"body",
"lungs",
"heart",
"125mg",
"water",
"reach",
"adults",
"doctor",
"Storage",
"Purpose",
"arteries",
"guidance",
"strength",
"moisture",
"children",
"Bosentan",
"headache",
"flushing",
"workload",
"frequency",
"substance",
"pregnancy",
"key points",
"absorption",
"right side",
"individuals",
"blood tests",
"Precautions",
"cyclosporine",
"Consultation",
"instructions",
"Effectiveness",
"liver enzymes",
"blood vessels",
"birth defects",
"Administration",
"PAH. Monitoring",
"HIV medications",
"room temperature",
"unusual symptoms",
"nasal congestion",
"exercise capacity",
"dosage adjustments",
"Regular monitoring",
"Common side effects",
"personalized advice",
"high blood pressure",
"healthcare provider",
"Bosentime 125 tablets",
"hormonal contraceptives",
"effective contraception",
"potential drug interactions",
"liver function abnormalities",
"endothelin receptor antagonist",
"pulmonary arterial hypertension"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1056,
"imageuri": "https://productimages.withfloats.com/actual/6634c5040b2293f75b95bb15.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6634c5040b2293f75b95bb15.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-05-03T11:04:09.715Z",
"updatedon": "2024-06-12T11:09:45.871Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//bosentime-125/1056",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Bosentan (125mg)",
"category": "ORTHOLOGYRANG",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68c29ba02244c906e7790e2b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TELAVINCE 300",
"description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.",
"price": 1480.0,
"discountamount": 444.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2179,
"imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-11T09:51:28.508Z",
"updatedon": "2025-09-11T09:51:28.508Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg",
"category": "GENERAL RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68beb577cb617ef27c577d94",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "CEPHODOXIAA 50 DS",
"description": "CEPHODOXIAA 50 DS is an oral suspension containing Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic. It is widely prescribed for the treatment of bacterial infections in adults and children, including infants and babies.Oral suspension form is particularly useful for children and patients who have difficulty swallowing tablets, ensuring accurate dosing and better compliance.\nComposition\nActive Ingredient: Cefpodoxime Proxetil 50 mg per 5 ml suspension\nBrand Name: CEPHODOXIAA 50 DS\nForm: Oral Suspension\nDrug Class: Cephalosporin Antibiotic\nExcipients: Flavors, sweeteners, stabilizers for palatability and suspension stability\nCefpodoxime Proxetil Oral Suspension IP Uses\nCEPHODOXIAA 50 DS is prescribed for a wide variety of bacterial infections:\nRespiratory Tract Infections\nTonsillitis, Pharyngitis\nBronchitis and Pneumonia\nEar, Nose & Throat (ENT) Infections\nAcute Sinusitis\nOtitis Media (middle ear infection)\nUrinary Tract Infections (UTIs)\nCystitis and kidney infections\nSkin & Soft Tissue Infections\nImpetigo, Cellulitis\nInfected wounds and abscesses\nOther Indications\nGonorrhea (in selected cases)\nPediatric bacterial infections where oral dosing is preferred\nFor babies and children: The oral suspension allows precise weight-based dosing, making it safe and convenient for pediatric infections.\nHow Cefpodoxime Proxetil Oral Suspension Works\nCefpodoxime Proxetil is a beta-lactam antibiotic that:\nInhibits bacterial cell wall synthesis\nWeakens bacterial cells, causing cell death\nEffective against both Gram-positive and Gram-negative bacteria\nThis mechanism helps control infections and prevents their spread.\nDosage & Administration \nInfants & Children: Dose is based on body weight and prescribed by a pediatrician.\nCommonly 5–10 mg/kg/day, divided into 2 doses daily.\nAdults: Typically 100–200 mg every 12 hours, depending on infection severity.\nAdministration Tips:\nShake the bottle well before use.\nUse the measuring cup or spoon provided for accurate dosing.\nCan be taken with or without food, but giving after meals may reduce stomach upset.\nComplete the full course even if symptoms improve.\nBenefits of Cefpodoxime Proxetil Oral Suspension\nEasy to administer for children and babies\nBroad-spectrum coverage for respiratory, urinary, and skin infections\nHelps in rapid infection control\nSafe and effective with minimal side effects when taken as prescribed\nSuspension form allows accurate weight-based dosing\nSide Effects of Cefpodoxime Proxetil Oral Suspension\nMild side effects may include:\nDiarrhea or loose stools\nNausea or vomiting\nStomach pain\nHeadache or dizziness\nSkin rash or itching\nSerious side effects (rare):\nSevere allergic reaction (swelling, rash, difficulty breathing)\nSevere diarrhea indicating Clostridium difficile infection\nLiver enzyme elevation\nSeek medical attention if any severe or persistent side effects occur.\nPrecautions & Warnings\nAvoid if allergic to cephalosporins, penicillin, or other beta-lactam antibiotics\nUse cautiously in patients with kidney or liver disease\nNot effective against viral infections like flu or common cold\nPregnant or breastfeeding women should consult a doctor before use\nAlways complete the full prescribed course to prevent antibiotic resistance\nDrug Interactions\nAntacids containing magnesium or aluminum may reduce absorption\nProton pump inhibitors (PPIs) like omeprazole\nBlood thinners (e.g., warfarin – monitor for increased bleeding risk)\nOther antibiotics may interact and alter effectiveness\nConclusion\nCEPHODOXIAA 50 DS (Cefpodoxime Proxetil Oral Suspension IP) is a safe and effective solution for treating bacterial infections in adults, children, and babies.",
"price": 100.0,
"discountamount": 30.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2178,
"imageuri": "https://productimages.withfloats.com/actual/68beb57bed36b14275f756c2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68beb57bed36b14275f756c2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-08T10:52:39.162Z",
"updatedon": "2025-09-08T10:52:39.162Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-50-ds/2178",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "cefpodoxime proxetil oral suspension ip 50 mg",
"category": "Pediatric",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}